Vaccine guidance shifts, insulin pricing pressure and FDA review activity top today’s news

January 6, 2026

1. HHS overhauls childhood vaccine recommendations: 4 things to know Full story

2. 5 updates on FDA's expedited drug review activity Full story

3. Drug shortages are daily threats. UVA Health shows their strategies to restore control here.

 

4. Indiana sues Eli Lilly over insulin pricing Full story

5. Civica Rx's low-cost insulin, biosimilar launch in US Full story

6. Waste reduction without burnout is possible. Ardent's 30-day inpatient care turnaround here.

 

7. Amneal wins FDA approval for 2 biosimilars Full story

8. FDA rejects cortisol modulator for hypertension Full story

9. Notable healthcare policies taking effect in 2026 Full story

10. Wyoming system names CEO Full story

11. Why CFOs can't play the 'financial scorekeeper' in 2026 Full story

 

12. OR inefficiencies persist. WakeMed, Lee Health + Cone Health cracked the code: details here.

Becker's Learning Opportunities

13. How are peers making purchasing calls ahead of 2026? Benchmark your strategy here.

14. Inside WakeMed's 10%+ gain in surgical capacity: Their chief medical officer explains here.

15. 1 switch, 130+ hours saved: see this California hospital's winning pharmacy strategy here.

16. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 

 

Contact Us, Feedback, or Questions – Email ptwenter@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication